TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” second-quarter investor letter. A copy of the same can be downloaded here. In the ...
Hosted on MSN
Will Reta rewrite obesity?
My social media feed has been blowing up over what’s being predicted to become a “trillion-dollar drug,” — Retatrutide, a.k.a. “Reta” a.k.a. “GLP-3” Retatrutide represents the third generation of ...
After several tireless days we have finished crunching the numbers from nearly 900 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which ...
Add Yahoo as a preferred source to see more of our stories on Google. ELKHART — Reason Enough to Act now offers anger management classes for men and women. “At RETA, we aim to provide trauma-informed ...
In recent trading, shares of Reata Pharmaceuticals Inc (Symbol: RETA) have crossed above the average analyst 12-month target price of $119.18, changing hands for $167.19/share. When a stock reaches ...
Reata Pharmaceuticals, Inc. (NASDAQ:RETA) shareholders should be happy to see the share price up 26% in the last month. But that hardly compensates for the shocking decline over the last twelve months ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results